140 related articles for article (PubMed ID: 38284676)
1. A rare case of severe tricuspid regurgitation caused by TIPS stent migrating into the right atrium.
Seçkin Göbüt Ö; Ünlü S; Özgül S; Moral K
Echocardiography; 2024 Jan; 41(1):e15730. PubMed ID: 38284676
[TBL] [Abstract][Full Text] [Related]
2. A rare case of severe tricuspid regurgitation caused by detached stent falling into the right ventricle after transjugular intrahepatic portosystemic shunt.
Xiong F; Tan K; Cheng L; Luo Y; Zhao Z
J Cardiothorac Surg; 2022 Mar; 17(1):42. PubMed ID: 35305677
[TBL] [Abstract][Full Text] [Related]
3. Migration of intrahepatic portosystemic stent into right ventricle: An unusual cause of tricuspid regurgitation.
Linka AZ; Jenni R
Circulation; 2001 Jan; 103(1):161-2. PubMed ID: 11136702
[No Abstract] [Full Text] [Related]
4. Atrial septal perforation from TIPS stent migration.
Hayashi PH; Mao J; Slater K; Liao R; Durham JD; Carroll J; Everson GT; Kam I; Forman LM
J Vasc Interv Radiol; 2004 Jun; 15(6):629-32. PubMed ID: 15178725
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
[No Abstract] [Full Text] [Related]
6. Expanded polytetrafluoroethylene (ePTFE)-covered stents versus bare stents for transjugular intrahepatic portosystemic shunt in people with liver cirrhosis.
Zhu P; Dong S; Sun P; Belgaumkar AP; Sun Y; Cheng X; Zheng Q; Li T
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012358. PubMed ID: 37531575
[TBL] [Abstract][Full Text] [Related]
7. Transient hemodynamic instability caused by TIPS.
Schneider D; Kojecký V
Vnitr Lek; 2023; 69(E-4):16-19. PubMed ID: 37468318
[TBL] [Abstract][Full Text] [Related]
8. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis.
Bhogal HK; Sanyal AJ
Clin Gastroenterol Hepatol; 2011 Nov; 9(11):936-46; quiz e123. PubMed ID: 21699820
[TBL] [Abstract][Full Text] [Related]
9. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
10. Recanalization of an occluded intrahepatic portosystemic covered stent via the percutaneous transhepatic approach.
Chan CY; Liang PC
Korean J Radiol; 2010; 11(4):469-71. PubMed ID: 20592931
[TBL] [Abstract][Full Text] [Related]
11. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
Colombato L
J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
Tan HK; James PD; Sniderman KW; Wong F
J Gastroenterol Hepatol; 2015 Feb; 30(2):389-95. PubMed ID: 25168607
[TBL] [Abstract][Full Text] [Related]
13. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
[TBL] [Abstract][Full Text] [Related]
14. Early and long-term clinical and radiological follow-up results of expanded-polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunt procedures.
Maleux G; Nevens F; Wilmer A; Heye S; Verslype C; Thijs M; Wilms G
Eur Radiol; 2004 Oct; 14(10):1842-50. PubMed ID: 15221261
[TBL] [Abstract][Full Text] [Related]
15. Cardiac perforation due to Wallstent embolization: a fatal complication of the transjugular intrahepatic portosystemic shunt procedure.
Prahlow JA; O'Bryant TJ; Barnard JJ
Radiology; 1997 Oct; 205(1):170-2. PubMed ID: 9314980
[TBL] [Abstract][Full Text] [Related]
16. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.
Armstrong MJ; Gohar F; Dhaliwal A; Nightingale P; Baker G; Greaves D; Mangat K; Zia Z; Karkhanis S; Olliff S; Mehrzad H; Steeds RP; Tripathi D
Aliment Pharmacol Ther; 2019 Mar; 49(6):797-806. PubMed ID: 30773660
[TBL] [Abstract][Full Text] [Related]
17. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
[TBL] [Abstract][Full Text] [Related]
19. Delayed liver laceration following transjugular intrahepatic portosystemic shunt for portal hypertension.
Liu K; Fan XX; Wang XL; He CS; Wu XJ
World J Gastroenterol; 2012 Dec; 18(48):7405-8. PubMed ID: 23326153
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
Rajesh S; George T; Philips CA; Ahamed R; Kumbar S; Mohan N; Mohanan M; Augustine P
World J Gastroenterol; 2020 Oct; 26(37):5561-5596. PubMed ID: 33088154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
